MedWatch

Successful service business finances Nordic Bioscience's research

Danish CRO and biotech firm Nordic Bioscience profits so much from its biomarkers and clinical trial services that the company is able to finance its own research projects. The goal is to become a leader in precision medicine development.

Morten Karsdal, CEO of Nordic Bioscience | Foto: Nordic Bioscience

Danish biotech firm and contract research organization (CRO) Nordic Bioscience has high ambitions: to play a central role in the development of personalized medicine.

And with positive financial results from the service business in 2018, the firm is closer than ever to fulfill this ambition.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier